Showing 1851-1860 of 1969 results for "".
- Deadline Extended for Medical Spa State of the Industry Statistical Studyhttps://modernaesthetics.com/news/deadline-extended-for-medical-spa-state-of-the-industry-statistical-study/2472272/The American Med Spa Association (AmSpa) has extended the deadline for the 2017 Medical Spa St
- In a Week of Surprising Acquisitions, Will Syneron Be Next?https://modernaesthetics.com/news/in-a-week-of-surprising-acquisitions-will-syneron-be-next/2472276/Hot off the heels of Allergan’s acquisition of Zeltiq and Hologic Inc,’s surprising purchase of Cynosure Inc., media reports are now swirling that British private equity fund Apax Partners is looking to buy Syneron Medical for $350-$400 million. According to Israeli finan
- Allergan Agrees to Acquire ZELTIQ for $2.47 Billionhttps://modernaesthetics.com/news/allergan-agrees-to-acquire-zeltiq-for-247-billion/2472280/Allergan plc and ZELTIQ® Aesthetics, Inc. have entered into a definitive agreement under which Allergan has agreed to acquire ZELTIQ for $56.50 per share, or $2.475 billion, subject to customary
- Allergan Launches Juvéderm Volitehttps://modernaesthetics.com/news/allergan-launches-juvderm-volite/2472287/Allergan plc launched Juvéderm Volite, an injectable product specifically designed to improve skin quality and last up to nine months with just one treatment session. This innovative new Allergan product uses the unique patented Vycross technology. The new HA injectable treatment d
- FDA Approves Restylane Refyne and Restylane Defyne Dermal Fillers for “Laugh Lines”https://modernaesthetics.com/news/fda-approves-restylane-refyne-and-restylane-defyne-dermal-fillers-for-laugh-lines/2472303/The FDA has approved two new Galderma products for the treatment of nasolabial folds (NLF) or “laugh lines,” in patients over the age of 21. Restylane Refyne was approved for the treatment of moderate to severe facial wrinkles and folds and Restylane®
- Revealed: What A Girl Wants in a Plastic Surgeonhttps://modernaesthetics.com/news/revealed-what-a-girl-wants-in-a-plastic-surgeon/2472307/Nearly half of all female plastic surgery patients have no preference when it comes to the gender of their cosmetic surgeon, a new study show. Specifically, the report, published in Aesthetic Surgery Journal</
- Merz On The Move: Reflections On Fiscal Year 2015/16https://modernaesthetics.com/news/merz-on-the-move-reflections-on-fiscal-year-201516/2472311/Merz Pharma’s core business has grown by 8.9 percent from EUR 809.8 million to EUR 881.9 million in fiscal 2015/16, the company reports. The company’s total revenue of EUR 1,092.9 million has declined by 5.5 percent compared to previous year
- Recently Retired American Academy of Facial Plastic and Reconstructive Surgery CEO Receives AMA Lifetime Achievement Awardhttps://modernaesthetics.com/news/recently-retired-american-academy-of-facial-plastic-and-reconstructive-surgery-ceo-receives-ama-lifetime-achievement-award/2472317/The American Medical Association (AMA) has presented the Medical Executive Lifetime Achievement Award to Stephen C. Duffy, former executive vice president and CEO of the American Academy of Facial Plastic and Reconstructive Sur
- Syneron Candela's Profound SubQ FDA Approved to Improve Cellulitehttps://modernaesthetics.com/news/syneron-candelas-profound-subq-fda-approved-to-improve-cellulite/2472321/Syneron Candela received FDA 510(k) clearance for Profound when using the SubQ handpiece and cartridge to improve the appearance of cellulite in patients with Fitzpatrick skin types I-III, as supported by long term data (6 months). A recent multi-center clinical study of Profound sh
- John Josephhttps://modernaesthetics.com/profiles/john-joseph/L6KmYX/